Inventor · disambiguated record
Seonggu Ro
Also filed as: RO SEONGGU
6 granted patents·6 pending applications·43 citations·filing 2004–2022
78Inventor score
Top patents by PatentIndex Score
12 records- 0191US9758508B22,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2013·Granted Sep 12, 2017·33 cites·15 claims
- 0280US7973060B2Fab I inhibitor and process for preparing sameCRYSTALGENOMICS INC·Filed 2006·Granted Jul 5, 2011·4 cites·18 claims
- 0371US2022380346A12,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2022·Application pending·0 cites
- 0464US11230539B22,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2020·Granted Jan 25, 2022·0 cites·22 claims
- 0564US7179832B2Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereofYUYU INC·Filed 2004·Granted Feb 20, 2007·6 cites·6 claims
- 0662US10604508B22,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2017·Granted Mar 31, 2020·0 cites·22 claims
- 0749US10413520B2Oral pharmacological composition including 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone having crystalline structure with excellent stabilityCRYSTALGENOMICS INC·Filed 2017·Granted Sep 17, 2019·0 cites·9 claims
- 0848US2010311965A12-aminoquinazoline derivativeCARNA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 0942US2011028507A1Pyridine derivatives and methods of use thereofCRYSTALGENOMICS INC·Filed 2008·Application pending·0 cites
- 1042US2009170847A1Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing SameLEE SEUNG CHUL·Filed 2007·Application pending·0 cites
- 1138US2007254882A1Sulfamide Derivatives and Pharmaceutical Composition for Upregulation of Lipid Metabolism Comprising SameCRYSTAL GENOMICS INC·Filed 2005·Application pending·0 cites
- 1226US2017000759A1Pharmaceutical Composition Including 5--2,2-Dimethyl-4-(3-Fluorophenyl)-3(2H)-Furanone And Capsule Formulation Including The Pharmaceutical CompositionCRYSTALGENOMICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seonggu Ro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →